离岸价格
获取最新报价( Negotiable )
|100 Gram Minimum Order
国家:
China
型号:
IP0004-C
离岸价格:
( Negotiable ) 获取最新报价
位置:
china
最小订单价格:
-
最小订单:
100 Gram
包装细节:
Aluminum foil bag, PTFE Bottle, or meet your requirment
交货时间:
Within one week
供应能力:
1 Kilogram per Month
付款方式:
D/P, L/C, T/T
產品組 :
联系人 Mr. James
Building A, NO.688,Qiushi Road,Jinshan District, Shanghai, shanghai
Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug is being investigated as a single dose therapy, as well as in combination with chemotherapy.Pfizer submitted a new drug application for the treatment of advanced renal cell carcinoma based on the Phase III AXIS ***2 trial.The drug has been approved for review by the FDA in June ***1.The drug was also accepted for review by the European Medicines Agency in June ***1.The review will be based on the Phase III AXIS ***2 trial.More than **0,**0 people are diagnosed with renal cell carcinoma every year and **2,**0 people die as a result of the cancer.
| 国家: | China |
| 型号: | IP0004-C |
| 离岸价格: | ( Negotiable ) 获取最新报价 |
| 位置: | china |
| 最小订单价格: | - |
| 最小订单: | 100 Gram |
| 包装细节: | Aluminum foil bag, PTFE Bottle, or meet your requirment |
| 交货时间: | Within one week |
| 供应能力: | 1 Kilogram per Month |
| 付款方式: | D/P, L/C, T/T |
| 產品組 : | Pharma intermediate |
